160 related articles for article (PubMed ID: 7564509)
21. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.
Toksvang LN; De Pietri S; Nielsen SN; Nersting J; Albertsen BK; Wehner PS; Rosthøj S; Lähteenmäki PM; Nilsson D; Nystad TA; Grell K; Frandsen TL; Schmiegelow K
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28423235
[TBL] [Abstract][Full Text] [Related]
22. Report of the Cancer Therapy Evaluation Program monitoring plan for secondary acute myeloid leukemia following treatment with epipodophyllotoxins.
Smith MA; Rubinstein L; Cazenave L; Ungerleider RS; Maurer HM; Heyn R; Khan FM; Gehan E
J Natl Cancer Inst; 1993 Apr; 85(7):554-8. PubMed ID: 8455202
[TBL] [Abstract][Full Text] [Related]
23. Secondary acute myeloblastic leukemia in a child with acute lymphoblastic leukemia treated with epipodophyllotoxins.
Ozbek N; Cetin M; Tuncer AM; Yetgin S
Turk J Pediatr; 1995; 37(3):279-82. PubMed ID: 7502369
[TBL] [Abstract][Full Text] [Related]
24. True histiocytic lymphoma following therapy for lymphoblastic neoplasms.
Soslow RA; Davis RE; Warnke RA; Cleary ML; Kamel OW
Blood; 1996 Jun; 87(12):5207-12. PubMed ID: 8652834
[TBL] [Abstract][Full Text] [Related]
25. Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group.
Crist W; Shuster J; Look T; Borowitz M; Behm F; Bowman P; Frankel L; Pullen J; Krance R; Steuber P
Leukemia; 1992; 6 Suppl 2():162-6. PubMed ID: 1578922
[TBL] [Abstract][Full Text] [Related]
26. Low-dose oral etoposide-based induction regimen for children with acute lymphoblastic leukemia in first bone marrow relapse.
Hijiya N; Gajjar A; Zhang Z; Sandlund JT; Ribeiro RC; Rubnitz JE; Jeha S; Liu W; Cheng C; Raimondi SC; Behm FG; Rivera GK; Relling MV; Pui CH
Leukemia; 2004 Oct; 18(10):1581-6. PubMed ID: 15356657
[TBL] [Abstract][Full Text] [Related]
27. Unexpected pancytopenia following treatment of acute lymphoblastic leukemia.
Innes A; May PC; Pavlů J; Bain BJ
Am J Hematol; 2012 Apr; 87(4):412. PubMed ID: 21953481
[No Abstract] [Full Text] [Related]
28. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
[TBL] [Abstract][Full Text] [Related]
30. Nutritional state alterations in children with acute lymphoblastic leukemia during induction and consolidation of chemotherapy.
Mejía-Arangure JM; Fajardo-Gutíerrez A; Bernáldez-Ríos R; Rodríguez-Zepeda MC; Espinoza-Hernández L; Martínez-García MC
Arch Med Res; 1997; 28(2):273-9. PubMed ID: 9204621
[TBL] [Abstract][Full Text] [Related]
31. Parotid mucoepidermoid carcinoma following chemotherapy for childhood acute lymphoblastic leukemia.
Sandoval C; Jayabose S
Pediatr Hematol Oncol; 2001; 18(3):217-20. PubMed ID: 11293291
[TBL] [Abstract][Full Text] [Related]
32. Therapy-related acute myelomonocytic leukemia following successful treatment for acute promyelocytic leukemia.
Todisco E; Testi AM; Avvisati G; Moleti ML; Cedrone M; Cimino G; Mancini F; Amadori S; Mandelli F
Leukemia; 1995 Sep; 9(9):1583-5. PubMed ID: 7658728
[TBL] [Abstract][Full Text] [Related]
33. Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases.
Pui CH; Relling MV; Rivera GK; Hancock ML; Raimondi SC; Heslop HE; Santana VM; Ribeiro RC; Sandlund JT; Mahmoud HH
Leukemia; 1995 Dec; 9(12):1990-6. PubMed ID: 8609707
[TBL] [Abstract][Full Text] [Related]
34. [Report of a case with secondary acute promyelocytic leukemia after therapy for hemophagocytic lymphohistiocytosis and review of literature].
Su Y; Zhou X; Zhang L; Zhang R
Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):938-42. PubMed ID: 24495767
[TBL] [Abstract][Full Text] [Related]
35. [Molecular genetic detection of minimal residual disease (MRD) in children with acute lymphoblastic leukemia].
Koehler R; Bartram CR
Klin Padiatr; 2013 May; 225 Suppl 1():S40-4. PubMed ID: 23700054
[TBL] [Abstract][Full Text] [Related]
36. Neurological complications during treatment of childhood cancer: mind Wernicke encephalopathy.
La Spina M; Catania R; Lo Nigro L; De Grandi C; Palmucci S; Di Cataldo A
Pediatr Hematol Oncol; 2010 May; 27(4):320-3. PubMed ID: 20426524
[No Abstract] [Full Text] [Related]
37. Long-term results of the treatment of adolescents and adults with acute lymphoblastic leukemia with a pediatric-inspired regimen delivered on an outpatient basis: A single institution experience.
García-Villaseñor E; Cortés JE; Reyes-Cisneros OA; Fernández-Gutiérrez JA; Sánchez-Bonilla D; Bojalil-Álvarez L; Murrieta-Álvarez I; Ruiz-Delgado GJ; Ruiz-Argüelles GJ
Leuk Res; 2022 Oct; 121():106935. PubMed ID: 36037624
[TBL] [Abstract][Full Text] [Related]
38. Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia.
Relling MV; Yanishevski Y; Nemec J; Evans WE; Boyett JM; Behm FG; Pui CH
Leukemia; 1998 Mar; 12(3):346-52. PubMed ID: 9529129
[TBL] [Abstract][Full Text] [Related]
39. Unexpected mortality from the use of E. coli L-asparaginase during remission induction therapy for childhood acute lymphoblastic leukemia: a report from the Taiwan Pediatric Oncology Group.
Liang DC; Hung IJ; Yang CP; Lin KH; Chen JS; Hsiao TC; Chang TT; Pui CH; Lee CH; Lin KS
Leukemia; 1999 Feb; 13(2):155-60. PubMed ID: 10025887
[TBL] [Abstract][Full Text] [Related]
40. Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins.
Smith MA; Rubinstein L; Anderson JR; Arthur D; Catalano PJ; Freidlin B; Heyn R; Khayat A; Krailo M; Land VJ; Miser J; Shuster J; Vena D
J Clin Oncol; 1999 Feb; 17(2):569-77. PubMed ID: 10080601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
